SCHEMBL13612704

SCHEMBL13612704

Cc1cc(C(F)(C(F)(F)F)C(F)(F)F)ccc1NC(=O)c1cccc(C)c1C(=O)NC(C)(C)CS(C)(=N)=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 3/20 0.38
ALDH1A1 P00352 3/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
LMNA P02545 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
NPC1 O15118 1/20 0.37
MAPT P10636 1/20 0.37
ALOX15 P16050 1/20 0.37
MAPK1 P28482 1/20 0.37
RAB9A P51151 1/20 0.37
HSD17B10 Q99714 1/20 0.37
P2RX1 P51575 1/20 0.36
EPHX2 P34913 1/20 0.36
GAA P10253 2/20 0.35
PPARG P37231 2/20 0.35
NR1H4 Q96RI1 1/20 0.35
TP53 P04637 1/20 0.34
THRB P10828 1/20 0.34
PTGES O14684 2/20 0.34
PLA2G7 Q13093 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13612662 0.93 RXFP1 (0.36) RXFP1ALDH1A1SMN1; SMN2LMNAL3MBTL1
SCHEMBL12996758 0.93 ALDH1A1 (0.38) RXFP1ALDH1A1SMN1; SMN2LMNAL3MBTL1
SCHEMBL13612670 0.92 TP53 (0.39) RXFP1ALDH1A1SMN1; SMN2LMNAMAPT
SCHEMBL861380 0.85 ALDH1A1 (0.42) RXFP1ALDH1A1SMN1; SMN2LMNAL3MBTL1
Flubendiamide SCHEMBL4054589 0.85 EPHX2 (0.36) RXFP1ALDH1A1SMN1; SMN2LMNAL3MBTL1
Flubendiamide SCHEMBL27362 0.85 EPHX2 (0.36) RXFP1ALDH1A1SMN1; SMN2LMNAL3MBTL1
Flubendiamide SCHEMBL29369179 0.85 EPHX2 (0.36) RXFP1ALDH1A1SMN1; SMN2LMNAL3MBTL1
Flubendiamide SCHEMBL15798517 0.84 EPHX2 (0.35) RXFP1ALDH1A1SMN1; SMN2LMNAL3MBTL1
SCHEMBL5486752 0.83 EPHX2 (0.35) RXFP1ALDH1A1SMN1; SMN2LMNAL3MBTL1
SCHEMBL23336560 0.82 EPHX2 (0.39) RXFP1ALDH1A1SMN1; SMN2LMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612018-B2 Insecticides SYNGENTA CROP PROTECTION, INC. (US) 2009-11-03 US disclosed
US-7612018-B2 Insecticides SYNGENTA CROP PROTECTION, INC. (US) 2009-11-03 US disclosed
US-20080214393-A1 Novel Insecticides SYNGENTA CROP PROTECTION, INC. (US) 2008-09-04 US disclosed
US-20080214393-A1 Novel Insecticides SYNGENTA CROP PROTECTION, INC. (US) 2008-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214393-A1 Novel Insecticides DDT, CYP4F11, ACHE RXFP1 4133/4885ALDH1A1 140/4885SMN1; SMN2 117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.